[ Price : $8.95]
Eight Hyman, Phelps & McNamara attorneys analyze a House Appropriations Committee report that explains its rationale and expectati...[ Price : $8.95]
The Federal Trade Commission files an amicus brief supporting plaintiffs in an antitrust lawsuit accusing Johnson & Johnson of unl...[ Price : $8.95]
A new CDER Office of New Drugs webinar discusses the development and use of OND Custom Medical Queries to identify potential safet...[ Price : $8.95]
Harmed Americans for Reform in Medical Device Safety petitions FDA to require an IDE for the Vena MicroAngioscope and take other s...[ Price : $8.95]
Speaking at a BIO International Convention FDA Town Hall, several agency executives cite increases in hiring and decreases in attr...[ Price : $8.95]
A new analysis published in JAMA Psychiatry raises fresh questions about how FDA evaluates drug efficacy when clinical trial resul...[ Price : $8.95]
FDA grants Pfizer expanded approval for Ibrance in combination with trastuzumab, with or without pertuzumab, and endocrine therapy...[ Price : $8.95]
FDA publishes a report summarizing demographic information from pivotal trials supporting 46 novel new drugs approved in 2025.